MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation
NYSE:MOH • US60855R1005
Current stock price
148.97 USD
+0.1 (+0.07%)
At close:
147.05 USD
-1.92 (-1.29%)
Pre-Market:
This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MOH Profitability Analysis
1.1 Basic Checks
- In the past year MOH was profitable.
- In the past year MOH has reported a negative cash flow from operations.
- MOH had positive earnings in each of the past 5 years.
- Of the past 5 years MOH 4 years had a positive operating cash flow.
1.2 Ratios
- MOH has a Return On Assets of 3.03%. This is in the better half of the industry: MOH outperforms 63.00% of its industry peers.
- MOH's Return On Equity of 11.60% is fine compared to the rest of the industry. MOH outperforms 77.00% of its industry peers.
- MOH has a better Return On Invested Capital (7.39%) than 70.00% of its industry peers.
- MOH had an Average Return On Invested Capital over the past 3 years of 14.32%. This is significantly above the industry average of 8.51%.
- The last Return On Invested Capital (7.39%) for MOH is well below the 3 year average (14.32%), which needs to be investigated, but indicates that MOH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROIC | 7.39% |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
1.3 Margins
- MOH has a Profit Margin (1.04%) which is comparable to the rest of the industry.
- MOH's Profit Margin has declined in the last couple of years.
- MOH's Operating Margin of 1.73% is in line compared to the rest of the industry. MOH outperforms 47.00% of its industry peers.
- MOH's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 13.07%, MOH is doing worse than 67.00% of the companies in the same industry.
- MOH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% |
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
2. MOH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MOH is still creating some value.
- MOH has less shares outstanding than it did 1 year ago.
- MOH has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, MOH has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.20 indicates that MOH is not in any danger for bankruptcy at the moment.
- MOH has a Altman-Z score of 4.20. This is in the better half of the industry: MOH outperforms 79.00% of its industry peers.
- MOH has a Debt/Equity ratio of 0.97. This is a neutral value indicating MOH is somewhat dependend on debt financing.
- MOH has a worse Debt to Equity ratio (0.97) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.2 |
ROIC/WACC0.88
WACC8.42%
2.3 Liquidity
- MOH has a Current Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of MOH (1.69) is better than 68.00% of its industry peers.
- MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.69, MOH is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 |
3. MOH Growth Analysis
3.1 Past
- The earnings per share for MOH have decreased strongly by -52.98% in the last year.
- The Earnings Per Share has been decreasing by -0.02% on average over the past years.
- MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.75%.
- Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 18.52% on average per year.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
3.2 Future
- MOH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.69% yearly.
- MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.17% yearly.
EPS Next Y-47.46%
EPS Next 2Y-7.58%
EPS Next 3Y7.72%
EPS Next 5Y21.69%
Revenue Next Year-1.15%
Revenue Next 2Y1.97%
Revenue Next 3Y2.88%
Revenue Next 5Y4.17%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. MOH Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 13.99, MOH is valued correctly.
- Compared to the rest of the industry, the Price/Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 85.00% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of MOH to the average of the S&P500 Index (27.89), we can say MOH is valued slightly cheaper.
- A Price/Forward Earnings ratio of 26.62 indicates a quite expensive valuation of MOH.
- MOH's Price/Forward Earnings ratio is in line with the industry average.
- MOH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.50.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.99 | ||
| Fwd PE | 26.62 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -0.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.58%
EPS Next 3Y7.72%
5. MOH Dividend Analysis
5.1 Amount
- MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOH Fundamentals: All Metrics, Ratios and Statistics
148.97
+0.1 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-22 2026-04-22/amc
Inst Owners104.7%
Inst Owner Change0.17%
Ins Owners1.41%
Ins Owner Change10.63%
Market Cap7.76B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target149.78 (0.54%)
Short Float %6.73%
Short Ratio1.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-4.39%
PT rev (3m)-14.7%
EPS NQ rev (1m)-7.37%
EPS NQ rev (3m)-47.92%
EPS NY rev (1m)-28.04%
EPS NY rev (3m)-59.12%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-6.22%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-4.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.99 | ||
| Fwd PE | 26.62 | ||
| P/S | 0.17 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.91 | ||
| P/tB | 4.14 | ||
| EV/EBITDA | -0.57 |
EPS(TTM)10.65
EY7.15%
EPS(NY)5.6
Fwd EY3.76%
FCF(TTM)-12.21
FCFYN/A
OCF(TTM)-10.27
OCFYN/A
SpS872.07
BVpS78.11
TBVpS35.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number136.815 (-8.16%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROCE | 9.57% | ||
| ROIC | 7.39% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% | ||
| FCFM | N/A |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.03 | ||
| Cap/Depr | 51.79% | ||
| Cap/Sales | 0.22% | ||
| Interest Coverage | 4.33 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.2 |
F-Score4
WACC8.42%
ROIC/WACC0.88
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-47.46%
EPS Next 2Y-7.58%
EPS Next 3Y7.72%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year-1.15%
Revenue Next 2Y1.97%
Revenue Next 3Y2.88%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-30.47%
EBIT Next 3Y3.63%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A
MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 4 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 2 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.
Can you provide the profitability details for MOLINA HEALTHCARE INC?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.
How financially healthy is MOLINA HEALTHCARE INC?
The financial health rating of MOLINA HEALTHCARE INC (MOH) is 5 / 10.